EHAB · Enhabit, Inc.
$13.80
+0.00 (+0.00%)
At close · May 14
Market Cap
$706.91M
Shares
51.23M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$13.80
Open$13.79
Day$13.79–13.81
Available close range$13.80–13.80
Avg vol available · 1d653K
Short int140K · 0.3% float · 1.0d
Short vol63%
Last earningsMar 5, 2026
DataMay 2026–May 2026
Filing10-Q · May 7
The closing range uses available history since May 14, 2026; less than a full year is stored.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 7, 2026
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Limited
Momentum
Limited
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Limited
Market backdrop
VIX 14.9 · calm
Equity put/call 0.52
Technical
price trend
Not enough data for a confident read.
Momentum
relative strength
Not enough data for a confident read.
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Distributing
-99% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.27% of float · ▼ -88.4% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
1 holders — near 3-yr low, contrarian setup
Fundamentals
Revenue growth
+2%
Y/Y
EPS growth
+97%
Y/Y
Free cash flow
$65.8M
Balance sheet
$404.7M
net debt
Quant / Vol
risk profile
Not enough data for a confident read.
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Prior guidance
period ended
· from the 8-K filed Aug 6, 2025
Net service revenue
· 2025
$1.06B – $1.07B
Adjusted EBITDA
· 2025
$104M – $108M
Adjusted EPS
· 2025
$0.47 – $0.55
Guided vs delivered
· last 1 settled
Net service revenue
2025
guided $1.06B – $1.07B
$1.06B
In line
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Distributing
-99% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.27% of float · ▼ -88.4% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
1 holders — near 3-yr low, contrarian setup
Price context
position in its available closing range
Price range unavailable — no recent comparable closes.
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted diluted EPS non-GAAP | $0.14 | Q4 | — |
| Adjusted EBITDA margin non-GAAP | 10.4% | Q4 | — |
| Cost per patient day (Home health) | $27.8 | Q4 | — |
| Cost per visit (Home health) | $102 | Q4 | — |
| De novo locations opened | 4 | Q4 | — |
| Home health cost per patient day change | -3.5% | Q4 | — |
| Home health year-over-year admissions growth | 7.3% | Q4 | — |
| Hospice ADC growth | 9.9% | Q4 | — |
| Hospice Adjusted EBITDA growth non-GAAP | 2.3% | Q4 | — |
| Hospice admissions growth | 0.8% | Q4 | — |
| Hospice cost per patient day change | 0.6% | Q4 | — |
| Leverage ratio | 3.7 | Q4 | — |
| Medicare ADC sequential decline | -1.7% | Q4 | — |
| Medicare admissions (Home health) | 22,196 | Q4 | — |
| Medicare average daily census (Home health) | 19,030 | Q4 | — |
| Medicare completed episodes (Home health) | 38,077 | Q4 | — |
| Medicare recertifications (Home health) | 15,203 | Q4 | — |
| Medicare visits (Home health) | 490,281 | Q4 | — |
| Non-Medicare admissions (Home health) | 34,582 | Q4 | — |
| Non-Medicare average daily census (Home health) | 23,294 | Q4 | — |
| Non-Medicare recertifications (Home health) | 14,840 | Q4 | — |
| Non-Medicare visits (Home health) | 574,023 | Q4 | — |
| Revenue per episode (Medicare, Home health) | $2,931 | Q4 | — |
| Revenue per patient day (Home health) | $53.1 | Q4 | — |
| Same-store total admissions growth (Home health) | 7.2% | Q4 | — |
| Same-store total recertifications growth (Home health) | 0.7% | Q4 | — |
| Segment Adjusted EBITDA margin (Home health) non-GAAP | 17.9% | Q4 | — |
| Total admissions (Home health) | 56,778 | Q4 | — |
| Total average daily census (Home health) | 42,324 | Q4 | — |
| Total recertifications (Home health) | 30,043 | Q4 | — |
| Total visits (Home health) | 1,064,304 | Q4 | — |
| Visits per episode (Medicare, Home health) | 12.9 | Q4 | — |
| Visits per episode (Total, Home health) | 12.5 | Q4 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
EHAB
this stock
Enhabit, Inc.
|
$706.91M | — | +2.4% | — | 0.3% |
|
HCA
HCA Healthcare, Inc.
|
$90.30B | -13.0% | +7.1% | 14.0 | 2.7% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$30.84B | -4.8% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$21.98B | +37.2% | +0.9% | 10.5 | 4.0% |
|
FMS
Fresenius Medical Care AG
|
$12.69B | -1.6% | +5.9% | — | 0.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| EHAB | — | — | — | — | — |
| SPY | +2.3% | +6.6% | +12.9% | +4.1% | +9.7% |
| vs SPY | — | — | — | — | — |